Emperra GmbH E-Health Technologies is dedicated to developing innovative digital health solutions to ease the daily life of people with diabetes mellitus.

The company’s flagship product, ESYSTA, automatically records insulin units and blood glucose measurements, fully automating the diabetes diary and providing a complete data basis for better therapy management. It enables patients and authorized healthcare professionals to keep all diabetes data in view anytime and anywhere, facilitating quick and easy therapy adjustments.

Emperra is led by an experienced management team, including founder and CEO Dr. med. Janko Schildt. The team has extensive expertise in clinical practice, regulatory affairs, product innovation, finance, and technical development for digital health solutions.

They work with specialists in hardware and software to realize their entrepreneurial goals and maintain international competitiveness.